Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reisa Sperling

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Science Advances|March 5, 2025
Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer's diseaseGillian T Coughlan, Zoe Rubinstein, Hannah Klinger, et al.
Neurobiology of Aging|January 8, 2019
Seizures as an early symptom of autosomal dominant Alzheimer's diseaseJonathan Vöglein, Soheyl Noachtar, Eric McDade, et al.
Nature Reviews. Neurology|March 1, 2024
Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsJoseph Therriault, Suzanne E Schindler, Gemma Salvadó, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
JAMA Neurology|April 3, 2023
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission TomographyGillian T Coughlan, Tobey J Betthauser, Rory Boyle, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Science Advances|March 5, 2025
Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer's diseaseGillian T Coughlan, Zoe Rubinstein, Hannah Klinger, et al.
Neurobiology of Aging|January 8, 2019
Seizures as an early symptom of autosomal dominant Alzheimer's diseaseJonathan Vöglein, Soheyl Noachtar, Eric McDade, et al.
Nature Reviews. Neurology|March 1, 2024
Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsJoseph Therriault, Suzanne E Schindler, Gemma Salvadó, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
JAMA Neurology|April 3, 2023
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission TomographyGillian T Coughlan, Tobey J Betthauser, Rory Boyle, et al.
Pageof 10